Jin Sun Lee Susan E Yost Yuan Yuan
10.3389/fonc.2020.582185
Front Oncol
2021 Jan 11;10:582185.
immune checkpoint inhibitors lenvatinib pembrolizumab personalized treatment triple negative breast cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/33505906/
Case Reports
PMC7830150
33505906
Case Report: Significant Response to the Combination of Lenvatinib and Immune Checkpoint Inhibitor in a Patient With Heavily Pretreated Metastatic Triple Negative Breast Cancer
2021